CS/CS/CS/HB 1509: Prescription Drugs
GENERAL BILL by Health & Human Services Committee ; Appropriations Committee ; Healthcare Regulation Subcommittee ; Chaney ; (CO-INTRODUCERS) Abbott ; Amesty ; Anderson ; Baker ; Bankson ; Barnaby ; Bartleman ; Bell ; Caruso ; Cross ; Gonzalez Pittman ; Gossett-Seidman ; Gottlieb ; Jacques ; Killebrew ; Leek ; Lopez, V. ; Massullo ; Melo ; Salzman ; Steele ; Tuck ; Waldron ; Woodson
Prescription Drugs; Requires drug manufacturers to notify DBPR of reportable drug price increases; prohibits manufacturers from claiming public records exemption for trade secrets for information provided in forms or reports; requires DFS to designate employee as primary contact on issues relating to PBMs; provides penalty for persons who do not hold certificate of authority to act as administrator; requires PBMs to identify ownership affiliations to office; provides requirements for contracts between PBM & participating pharmacy; provides for biennial examinations of PBMs. APPROPRIATION: $1,127,525
Last Action: 5/1/2023 House - Laid on Table; companion bill(s) passed, see CS/CS/SB 1550 (Ch. 2023-29), CS/SB 1552 (Ch. 2023-30)
Bill Text: PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 3/6/2023 | House |
• Filed |
| 3/7/2023 | House |
• 1st Reading (Original Filed Version) |
| 3/9/2023 | House |
• Referred to Healthcare Regulation Subcommittee • Referred to Appropriations Committee • Referred to Health & Human Services Committee • Now in Healthcare Regulation Subcommittee |
| 3/24/2023 | House |
• Added to Healthcare Regulation Subcommittee agenda |
| 3/28/2023 | House |
• Favorable with CS by Healthcare Regulation Subcommittee |
| 4/3/2023 | House |
• Reported out of Healthcare Regulation Subcommittee • Laid on Table under Rule 7.18(a) • CS Filed • 1st Reading (Committee Substitute 1) |
| 4/4/2023 | House |
• Referred to Appropriations Committee • Referred to Health & Human Services Committee • Now in Appropriations Committee |
| 4/20/2023 | House |
• Added to Appropriations Committee agenda |
| 4/21/2023 | House |
• Favorable with CS by Appropriations Committee • Reported out of Appropriations Committee • Laid on Table under Rule 7.18(a) • CS Filed |
| 4/22/2023 | House |
• Referred to Health & Human Services Committee • Now in Health & Human Services Committee |
| 4/23/2023 | House |
• Added to Health & Human Services Committee agenda |
| 4/24/2023 | House |
• Favorable with CS by Health & Human Services Committee • 1st Reading (Committee Substitute 2) • Reported out of Health & Human Services Committee |
| 4/25/2023 | House |
• Laid on Table under Rule 7.18(a) • CS Filed • Bill referred to House Calendar • 1st Reading (Committee Substitute 3) • Added to Second Reading Calendar |
| 5/1/2023 | House |
• Laid on Table; companion bill(s) passed, see CS/CS/SB 1550 (Ch. 2023-29), CS/SB 1552 (Ch. 2023-30) |
337637 - Amendment to Amendment (469723)